Scholars Central

Conference abstractPublished 30 Nov 2015

Lipid replacement therapy for enhancing mitochondrial function and improving chronic disease symptoms and aging

Authors: Garth L Nicolson

The Institute for Molecular Medicine, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Loss of function in mitochondria, the key cell organelle responsible for cellular energy production, can result in cell death, excess fatigue and other symptoms that are common problems in almost if not every chronic disease. These include: Neurodegenerative diseases, diabetes and metabolic syndrome, cardiovascular diseases, autoimmune diseases, neurobehavioral and psychiatric diseases, musculoskeletal and gastrointestinal diseases, fatiguing illnesses, cancer and chronic infections, among others. The molecular level reduction in mitochondrial function occurs when there is loss of mitochondrial maintenance and inner membrane trans-membrane potential due to oxidative damage by reactive oxygen species (ROS), resulting in reduced efficiency of the electron transport chain and less generation of ATP. Lipid replacement therapy (LRT) using an all-natural nutritional supplement mixture containing membrane glycerolphospholipids can be used to repair mitochondrial inner membrane damage, improve mitochondrial function, reverse ROS damage and increase the efficiency of the electron transport chain. Recent clinical trials have shown the benefits of lipid replacement therapy in enhancing mitochondrial function, reducing fatigue and improving mood and cognition. For example, mitochondrial function and inner membrane trans-membrane potential has been enhanced by 25-35%, resulting in decreases in fatigue by 35-45% in chronically ill patients in clinical trials. LRT has also been used to reduce the adverse effects of cancer chemotherapy and improve symptoms other than fatigue in chronic illness patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Glycomics & Lipidomics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycomics & Lipidomics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Garth L Nicolson”